Since the purchase and arrival of a Biacore S200 on May 2018, our In Vitro Assays and Screening team has been busy with adapting, developing and incorporating the SPR technology into our Assays and Sc
In May 2019, the new Tecnai G2 TF20 cryo-electron microscope is up and operational at Biortus. As the first and only CRO company in China with cryo-EM capability, Biortus now offers a better and more
On 09 January 2019, the first membrane-associated protein structure solved by Biortus was published in one of the world’s top journal Nature Communications (5-year Impact Factor = 13.691).
Biortus has passed the on-site verification of active pharmaceutical ingredient (API) Rivastigmine tartrate process development by a listed pharmaceutical company.